BBV154 intranasal Covid-19 vaccine...
Bharat Biotech, the company that makes the vaccine to protect against the corona virus (Covid-19), has achieved significant success in the trial of corona's nasal vaccine. The scientific name of this nasal vaccine is BBV154. Two types of trials were going on on the Nasal Vaccine. The first trial was going on with a two-dose primary vaccine of Corona and the second as a booster dose that could be administered to both the people who had taken the Covishield and Covaxin doses.
The human clinical trials of both of these have been completed and its data has been submitted to the drug controller. Trials of Corona's two-dose nasal vaccine were conducted on 3100 people. These trials have been done at 14 places in India.
Nasal vaccine reduces infection
Heterologous booster dose i.e. a vaccine that people who have got Covaxin and Coveshield will also be able to get it.
This vaccine has been made in collaboration with Bharat Biotech and Washington university St. Louis. The Department of Biotechnology, government of India, has partially funded this vaccine under the Covid Protection Program. This vaccine can also be stored at a temperature of 2 to 8 degrees.
